Skip to main content
. 2024 Dec 12;16(12):1589. doi: 10.3390/pharmaceutics16121589

Figure 2.

Figure 2

Deposition and analysis of aerosol droplets containing TRES-NLC particles of various formulations (F8, F14, and F22) in the various stages of a next-generation impactor (NGI) using (A) air-jet and (B) ultrasonic nebulizers at an airflow rate of 15 L/min. Data are presented as mean ± SD, n = 3.